American College of Physicians, Wisconsin Chapter, 2015 Abstracts

Total Page:16

File Type:pdf, Size:1020Kb

American College of Physicians, Wisconsin Chapter, 2015 Abstracts Wisconsin Chapter 2015 Abstracts Clinical Vignette and Research Competition Pages Case Based Vignettes ....................1-12 Research Based Vignettes ..........13-16 Displayed Posters ......................17-104 60th Annual Wisconsin Scientific Meeting Wilderness Resort, Wisconsin Dells, Wisconsin Case Based Vignettes SEVERE HYPOTHYROIDISM PRECIPITATING COMPARTMENT SYNDROME Craig Destree, MD and Rachel Hawker, MD, FACP Gundersen Medical Foundation, La Crosse, WI �������������������������������������������������������������2 THYROTOXIC PERIODIC PARALYSIS: A CASE REPORT Vidita Divan, MD; Samuel Godana, MD; Elaine Drobny, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ����������������3 REACTIVE SPONDYLOARTHROPATHY AFTER INFECTION WITH CHIKUNGUNYA VIRUS Kanchana Herath, MD; Appesh Mohandas, MD; David Gazeley, MD Medical College of Wisconsin, Milwaukee, WI �������������������������������������������������������������4 FULMINANT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TRIGGERED BY EBV Adam Hofer, MD and Sean O’Neill, MD University of Wisconsin, Madison, WI............................................................................5 CATASTROPHIC MODS FROM A MYSTERIOUS SOURCE Nadia Huq, MD; Abraham Getenet, MD; Zuber Ali, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ����������������6 EPSTEIN SYNDROME- A RARE CASE OF THROMBOCYTOPENIA Apoorva Jayarangaiah, MD1 and Narendranath Epperla, MD2 1Marshfield Clinic, Saint Joseph’s Hospital, Marshfield, WI 2Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI �����������������������7 A CURIOUS CASE OF CARDIAC ARREST Siddhartha Kattamanchi, MD; Victor Abrich, MD; Mazen Kreidy, MD Marshfield Clinic – St� Joseph’s Hospital, Marshfield, WI ��������������������������������������������8 A CASE OF CARDIAC SARCOIDOSIS John Nan, MD and Matthew Tattersall, DO, MS University of Wisconsin Hospital and Clinics, Madison, WI..........................................9 AN UNUSUAL CASE OF “HIGH” CPK Hari R� Pokhrel, MD; Christopher M� Lowry, DO; Deepa R� Ovian, MD Gundersen Lutheran Medical Foundation, La Crosse, WI� �������������������������������������������10 AN UNUSUAL CASE OF FEVER OF UNKNOWN ORIGIN Maura Steed, MD and Andrew Petroll, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������11 HEPATITIS B PREVALENCE IN THE MILWAUKEE HMONG COMMUNITY Timothy Wang; Heather Chou; Kia Saeian, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������12 i Research Based Vignettes ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: IMPACT OF DISEASE RISK AND CONDITIONING REGIMEN Jonathan Kapke, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������14 NUTRITIONAL PARAMETERS IN PREGNANT PATIENTS WITH INFLAMMATORY BOWEL DISEASE Abby Lochmann-Bailkey, MD and Sumona Saha, MD, MS University of Wisconsin School of Medicine and Public Health, Madison, WI ����������15 REDUCING READMISSION RATES IN ACUTE PANCREATITIS THROUGH PATIENT EDUCATION AND RISK ASSESSMENT Jordan Vulcano, DO and Anthony Caceres, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ��������������16 Displayed Posters 1) “HERE, EAT THIS ROOT!”: A CASE OF HERBAL MEDICATION INDUCED HEPATOTOXICITY Iliya Amaza, MD, MPH; Barkha Amlani, MD, MPH; Gary Van Oudenhoven, MD Marshfield Clinic and Ministry St� Joseph’s Hospital, Marshfield, WI ������������������������18 2) MALIGNANCY OR NOT? A CASE OF EXTRODINARILY ELEVATED CA 19-9 Laura Beacher, MD; Rima Thakkar, MD; Jaren Thomas, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������19 3) AURICULAR CHONDRITIS IN A PATIENT WITH ULCERATIVE COLITIS Alexandria Bear, MD and Irina Konon, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������20 4) STEVENS JOHNSON SYNDROME WITH TOXIC EPIDERMAL NECROLYSIS OVERLAP SYNDROME AS A RESULT OF HERBAL REMEDY Rebecca Blonsky, MD; Apoorva Jayarangaiah, MD; Jayanth Vedre, MD Marshfield Clinic and Saint Joseph’s Hospital, Marshfield, WI �����������������������������������21 5) AN SLE PATIENT WITH NECROTIZING LYMPHADENITIS Jared Bozeman; Kathleen Luskin, MD; Bipin Thapa, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������22 6) HIDA-ING IN PLAIN SIGHT – A 3-WEEK HOSPITALIZATION FOR BILIARY COLIC Austin Burdge; Daniel Sturgill, MD; Paul Bergl, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������23 7) INSULINOMA CAUSING REFRACTORY HYPOGLYCEMIA William Bzdawka, MD, PharmD University of Wisconsin Hospital and Clinics, Madison, WI........................................24 8) A LESS COMMON CAUSE OF SUPINE DYSPNEA AND THE IMPORTANCE OF THE PHYSICAL EXAM Ashish Chaddha, MD University of Wisconsin, Madison, WI..........................................................................25 ii Displayed Posters 9) RARE COMPLICATION OF RADIOFREQUENCY ABLATION Adithya Chennamadhavuni, MD; Inbar Saporta, MD; Michael Dolan, MD, FACP Gundersen Health System, La Crosse, WI.....................................................................26 10) IS 20 YEARS OLD TOO YOUNG FOR A STROKE? Yimenu Dagnew, MD; Raed Hamed, MD; Kern Reid, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI� �������������27 11) WHAT’S WITH THIS RASH? Kelly Delaney, MD; Inbar Saporta, MD; Steven Pearson, MD Gundersen Health System, La Crosse, WI.....................................................................28 12) AN AGGRESSIVE PROSTATE CANCER CAUSING DIZZINESS Vipal Durkal, MD and Kim Ridolfi, MD Medical College of Wisconsin Affiliated Hospitals� Milwaukee, WI ���������������������������29 13) BRAIN ABSCESS: THE GREAT MIMICKER Tesfaye Gebremedhin, MD and Richard Battiola, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ��������������30 14) AN ADULT CASE OF KERNICTERUS Abiy Gesese, MD; Netsanet Chalchisa, MD; Zuber Ali, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ��������������31 15) PANCYTOPENIA AS INITIAL PRESENTATION OF HODGKIN LYMPHOMA: A CASE REPORT Samuel Godana, MD and Magdalena Flejsierowicz, MD Aurora Heath Care Internal Medicine Residency Program, Milwaukee, WI ���������������32 16) ACE INHIBITORS & ARBS IN PERIOPERATIVE PERIOD Sameer Gupta, MD1; Aaron Dall, MD1; Chandra B�Chandran, MD2 1Medical College of Wisconsin, Milwaukee, WI 2St� Joseph’s Regional Medical Center, Paterson, NJ....................................................33 17) MUCORMYCOSIS OF THE MANDIBLE IN AN IMMUNOCOMPROMISED PATIENT Kathleen Hemauer, MD and Janaki Shah, DO Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������34 18) LEMMEL’S SYNDROME: LEAVING NO STONE UNTURNED Katie Hendrickson, MS4 and James Sebastian, MD, MACP Medical College of Wisconsin and the Zablocki VAMC, Milwaukee, WI �������������������35 19) THE USE OF TRIS-HYDROXYMETHYL AMINOMETHANE (THAM) TO TREAT A CASE OF SEVERE METFORMIN-INDUCED LACTIC ACIDOSIS Amber Hertz-Tang, MD1 and Charles Weber, MD2 1University of Wisconsin Hospital, Madison, WI 2Meriter Hospital, Madison, WI.....................................................................................36 20) WHAT GAVE IT AWAY? A CASE OF SYSTEMIC SCLEROSIS WITH SEVERE GASTROINTESTINAL DYSFUNCTION Elizabeth Hiatt, MD and Paul Bergl, MD Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������37 21) ARRHYTHMIA AND BLUES Aaron K� Ho, MD1; Sverrir I� Gunnarsson, MD2; Ryan T� Kipp, MD2 Departments of 1Internal Medicine and 2Cardiovascular Medicine, University of Wisconsin Hospital and Clinics, Madison, WI........................................38 iii Displayed Posters 22) A RARE CASE OF POST-INFECTIOUS CEREBELLITIS FROM EBV IN AN ADULT Adam Hofer, MD and Joan Addington-White, MD Department of Medicine, University of Wisconsin, Madison, WI ��������������������������������39 23) CHRONIC MYELOGENOUS LEUKEMIA (CML) PRESENTING AS A CASE OF de NOVO T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (t-LBL) Abel Irena, MD; Federico Sanchez, MD; Michael Thompson, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ��������������40 24) NON-ALCOHOLIC STEATOHEPATITIS (NASH) PRESENTING AS ACUTE LIVER FAILURE (ALF) Abel Irena, MD; Puneet Sidhu, MD; Julia Usatinsky, MD Aurora Health Care Internal Medicine Residency Program, Milwaukee, WI ��������������41 25) AN UNUSUAL CASE OF DVT: MAY-THURNER SYNDROME Apoorva Jayarangaiah, MD1; Rebecca Blonsky, MD1; Narendranath Epperla, MD2 1Marshfield Clinic, Saint Joseph’s Hospital, Marshfield, WI 2Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI ���������������������42 26) A RARE CASE OF POLYCYSTIC KIDNEY DISEASE ACQUIRED THROUGH RENAL TRANSPLANT Emily Joachim, MD and Arjang Djamali, MD University of Wisconsin School of Medicine and Public Health, Madison, WI ����������43 27) THE AFFORDABLE CARE ACT AND THE SPECIALTY ACCESS FOR THE UNINSURED PROGRAM Neerja Joshi; Gregory Stadter; Joan Neuner, MD, MPH Medical College of Wisconsin, Milwaukee, WI �����������������������������������������������������������44 28) A RARE CASE OF PAGET-SCHROETTER SYNDROME (PSS) Kriti Kalra, MD; Christopher Lowry, MD; Gregory Knorr, MD Gundersen Health System, La Crosse, WI.....................................................................45 29) REACTIVATION OF HEPATITIS
Recommended publications
  • MYH9-Related Platelet Disorders
    Reprinted with permission from Thieme Medical Publishers (Semin Thromb Hemost 2009;35:189-203) Homepage at www.thieme.com MYH9-Related Platelet Disorders Karina Althaus, M.D.,1 and Andreas Greinacher, M.D.1 ABSTRACT Myosin heavy chain 9 (MYH9)-related platelet disorders belong to the group of inherited thrombocytopenias. The MYH9 gene encodes the nonmuscle myosin heavy chain IIA (NMMHC-IIA), a cytoskeletal contractile protein. Several mutations in the MYH9 gene lead to premature release of platelets from the bone marrow, macro- thrombocytopenia, and cytoplasmic inclusion bodies within leukocytes. Four overlapping syndromes, known as May-Hegglin anomaly, Epstein syndrome, Fechtner syndrome, and Sebastian platelet syndrome, describe different clinical manifestations of MYH9 gene mutations. Macrothrombocytopenia is present in all affected individuals, whereas only some develop additional clinical manifestations such as renal failure, hearing loss, and presenile cataracts. The bleeding tendency is usually moderate, with menorrhagia and easy bruising being most frequent. The biggest risk for the individual is inappropriate treatment due to misdiagnosis of chronic autoimmune thrombocytopenia. To date, 31 mutations of the MYH9 gene leading to macrothrombocytopenia have been identified, of which the upstream mutations up to amino acid 1400 are more likely associated with syndromic manifestations than the downstream mutations. This review provides a short history of MYH9-related disorders, summarizes the clinical and laboratory character- istics, describes a diagnostic algorithm, presents recent results of animal models, and discusses aspects of therapeutic management. KEYWORDS: MYH9 gene, nonmuscle myosin IIA, May-Hegglin anomaly, Epstein syndrome, Fechtner syndrome, Sebastian platelet syndrome, macrothrombocytopenia The correct diagnosis of hereditary chronic as isolated platelet count reductions or as part of thrombocytopenias is important for planning appropri- more complex clinical syndromes.
    [Show full text]
  • State of Wisconsin - 2017
    State of WisconsinProvider Directory 2017 W9 MERCYCARE HMO INC. Live well. We’ll insure you do. Live well. We’ll insure you do. MercyCare ID Card MercyCare ID cards include: MercyCare Senior 6 1 INSURED NUMBER: Identification number 1 Insured Number Effective Date 2 Group Number xxx-xx-xxxx xxxxxx 2 GROUP NUMBER: How MercyCare identifies your benefit package 3 MEMBER NUMBER: Personal identification number 4 PCP NAME: Your primary care physician 3 Member Number Last Name 4 PCP Name (family medicine, internal medicine, xxx-xx-xxxx John Doe Dr. Smith pediatrician) 5 PLAN ID: Designates your plan 6 NAME OF PLAN: Type of plan you have Customer service department: (800) 895-2421 5 XX Important information to know: This provider list is the only paper version you will receive, unless you call our customer service department at (800) 895-2421 for additional copies. MercyCare encourages you to visit our website or contact customer service for the most current information regarding your provider network. To ensure accurate provider network listings, the on-line provider directory is continuously updated while the requestable paper directory is updated semi-annually only. Please visit www.mercycarehealthplans.com to see which providers participate in your plan. Above is an illustration of a MercyCare HMO membership card. To determine which plan you are in, please refer to your ID card. The card(s) you receive states the plan name, as well as the plan ID. Should you have any questions, or if you are unable to determine your specific plan name and/or plan ID, please call our customer service department at (800) 895-2421.
    [Show full text]
  • January - December 2019
    CPT/HCPCS Code: 45385 Lesion Removal Colonoscopy by Snare January - December 2019 Note: Utilization and charge data are per surgical episode. They may include procedures other than the principal procedure. STATEWIDE DATA Number Average Standard PERCENTILE CHARGES of Cases Charge Deviation 25th 50th 60th 70th 75th 80th 85th 90th 95th All Facilities 64,117 $5,442 $2,757 $3,521 $4,965 $5,332 $5,989 $6,670 $7,393 $8,227 $9,031 $10,342 FASCs 14,881 $4,423 $2,478 $2,660 $3,948 $4,965 $4,965 $5,198 $5,394 $5,955 $8,260 $9,930 Hospitals 49,236 $5,750 $2,762 $3,910 $5,185 $5,599 $6,445 $7,158 $7,707 $8,366 $9,208 $10,709 3 DIGIT ZIP CODE AREA 530** 7,702 $6,126 $2,642 $4,436 $5,556 $5,955 $6,634 $7,277 $8,005 $8,260 $8,925 $10,912 531** 7,497 $7,056 $3,821 $3,836 $7,180 $7,948 $8,755 $9,156 $9,623 $10,338 $11,983 $14,225 532** 8,056 $6,130 $3,191 $3,758 $5,955 $7,300 $7,846 $8,254 $8,397 $8,852 $9,734 $11,457 534** 1,102 $5,251 $1,616 $4,268 $4,700 $4,940 $5,307 $5,661 $6,126 $6,739 $7,292 $8,253 535** 3,589 $5,959 $2,105 $4,658 $5,501 $5,726 $6,173 $6,645 $6,948 $7,517 $8,720 $10,034 537** 5,852 $5,920 $2,316 $4,689 $4,965 $4,965 $5,051 $5,924 $7,547 $9,632 $9,930 $9,930 538** 242 $7,608 $2,293 $5,975 $6,913 $7,250 $8,829 $9,139 $9,719 $10,068 $10,523 $11,555 539** 1,503 $4,845 $1,348 $3,847 $4,685 $4,978 $5,219 $5,422 $5,645 $5,956 $6,345 $7,165 540** 650 $4,280 $979 $3,825 $4,147 $4,233 $4,335 $4,410 $4,496 $4,648 $4,917 $5,647 541** 959 $4,395 $1,971 $3,168 $3,692 $4,034 $5,184 $5,402 $5,889 $6,293 $7,030 $8,716 542** 853 $5,610 $1,338 $5,132
    [Show full text]
  • Protected Health Information Disclosure Authorization
    Froedtert Hospital 9200 West Wisconsin Avenue, Milwaukee, WI 53226-3596 Ph.414-805-2909 Fax 414-259-1244 Community Memorial Hospital of Menomonee Falls, Inc. d/b/a Froedtert Menomonee Falls Hospital W180 N8085 Town Hall Road, Menomonee Falls, WI 53051 Ph. 262-257-3415 Fax 262-253-7186 St. Joseph’s Community Hospital of West Bend, Inc. d/b/a Froedtert West Bend Hospital 3200 Pleasant Valley Road, West Bend, WI 53095 Ph. 262-836-2510 Fax 262-836-8490 Froedtert & the Medical College of Wisconsin Community Physicians (Hartford Health Center) 110 Lone Oak Lane, Hartford, WI 53027 Ph. 262-836-2510 Fax 262-836-8490 Froedtert Health Neighborhood Hospital, LLC d/b/a Froedtert Community Hospital 4805 S. Moorland Rd., New Berlin, WI 53150 Ph. 262-836-2510 Fax 262-836-8490 Please complete all items on the form. Mail, fax, or email ([email protected]) to Froedtert Hospital ATTN: Health Information Department or Hartford Health Center ATTN: Health Information Department. If you have any questions contact Health Information at the numbers above. 1. PATIENT INFORMATION: Patient Name: Date of Birth: Address: City/State/Zip: Phone #:____________________ Medical Record # (if known): 2. I AUTHORIZE INFORMATION TO BE RELEASED FROM: 3. I AUTHORIZE INFORMATION TO BE RELEASED TO: ☐ Drexel Surgery Center ☐ Froedtert Surgery Center ☐ Froedtert & the Medical College of ☐ Froedtert West Bend Hospital _____________________________________________________________ Wisconsin Community Physicians ☐ Lake Country Surgery Center Agency/Facility/Person
    [Show full text]
  • Alport Syndrome of the European Dialysis Population Suffers from AS [26], and Simi- Lar Figures Have Been Found in Other Series
    DOCTOR OF MEDICAL SCIENCE Patients with AS constitute 2.3% (11/476) of the renal transplant population at the Mayo Clinic [24], and 1.3% of 1,000 consecutive kidney transplant patients from Sweden [25]. Approximately 0.56% Alport syndrome of the European dialysis population suffers from AS [26], and simi- lar figures have been found in other series. AS accounts for 18% of Molecular genetic aspects the patients undergoing dialysis or having received a kidney graft in 2003 in French Polynesia [27]. A common founder mutation was in Jens Michael Hertz this area. In Denmark, the percentage of patients with AS among all patients starting treatment for ESRD ranges from 0 to 1.21% (mean: 0.42%) in a twelve year period from 1990 to 2001 (Danish National This review has been accepted as a thesis together with nine previously pub- Registry. Report on Dialysis and Transplantation in Denmark 2001). lished papers by the University of Aarhus, February 5, 2009, and defended on This is probably an underestimate due to the difficulties of establish- May 15, 2009. ing the diagnosis. Department of Clinical Genetics, Aarhus University Hospital, and Faculty of Health Sciences, Aarhus University, Denmark. 1.3 CLINICAL FEATURES OF X-LINKED AS Correspondence: Klinisk Genetisk Afdeling, Århus Sygehus, Århus Univer- 1.3.1 Renal features sitetshospital, Nørrebrogade 44, 8000 Århus C, Denmark. AS in its classic form is a hereditary nephropathy associated with E-mail: [email protected] sensorineural hearing loss and ocular manifestations. The charac- Official opponents: Lisbeth Tranebjærg, Allan Meldgaard Lund, and Torben teristic renal features in AS are persistent microscopic hematuria ap- F.
    [Show full text]
  • Cardiac Care Static List
    Centers for Cardiac Care Directory of Providers Updated: January 1, 2021 Blue Cross Blue Shield Association is an association of independent Blue Cross and Blue Shield companies. Blue Distinction® Centers for Cardiac Care Your Participating Provider Directory This Provider Directory is your guide to providers that have been designated as Blue Distinction Centers or Blue Distinction Centers+. We are continually updating this list. If you do not see a particular healthcare provider listed, need additional information regarding a provider or have any questions about your specific benefits, please call the customer service number on the back of your identification card. A provider’s participation in the program is subject to change. To verify this information, please contact the provider before you receive medical services. If this is an emergency, please proceed to the nearest healthcare provider with an emergency department. Blue Distinction Centers When it comes to your health and healthcare, the choices you make matter. Blue Distinction Centers can help you and your doctor have a better informed discussion about finding the right provider for the specific procedure you need. Blue Distinction Centers The Blue Distinction Center program was developed with input from the medical community and evaluates providers on their ability to deliver high quality and safe specialty care based on criteria that directly impact patient results – e.g., surgical team expertise and a history of better outcomes for patients. Blue Distinction Centers+ Blue Distinction Centers+ not only meet the same quality criteria as Blue Distinction Centers, but they also go a step further. Providers receiving a Blue Distinction Center+ designation are also measured on how efficiently they deliver this high-quality patient care.
    [Show full text]
  • Hospital Organ Donation Campaign Recognition for Outreach
    Hospital Organ Donation Campaign Recognition for Outreach The hospitals listed below reached gold, silver, and bronze recognition levels for their organ, eye, and tissue donation and registration efforts between August 1, 2014, and April 30, 2015. The hospitals worked closely with their organ procurement organizations and Donate Life America affiliates to educate and register new donors. In many states, the participation of state hospital associations was pivotal to the hospitals’ efforts. DLA and hospital association participation is indicated in the title line for each state. OPO participation is listed in the OPO recogni- tion list at the end of the document. SEARCH BY STATE: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z OPO RECOGNITION ALABAMA • Donate Life Alabama 1 0 0 East Alabama Medical Center Y ARIZONA • Donate Life Arizona 3 11 28 • Arizona Hospital and Healthcare Association Abrazo Arizona Heart Hospital Y Abrazo Central Campus Y Abrazo Scottsdale Campus Y Abrazo West Campus Y American Liver Foundation Y Banner Boswell Medical Center Y Banner Casa Grande Regional Medical Center Y Banner Del E. Webb Medical Center Y Banner Desert Medical Center and Cardon Children’s Medical Center Y Banner Estrella Medical Center Y Banner Gateway Medical Center and Banner MD Anderson Cancer Center Y Banner Goldfield Medical Center Y Banner Ironwood Medical Center Y Banner Thunderbird Medical Center Y Banner University Medical Center—Tucson and South Campus* Y Barnet Dulaney Perkins Eye Center Y Carondelet St. Mary’s Hospital Y Chandler Regional Medical Center Y Cobre Valley Regional Medical Center Y Flagstaff Medical Center Y * denotes transplant centers 1 HonorHealth Deer Valley Medical Center Y HonorHealth John C.
    [Show full text]
  • Gundersen Health Plan, Inc
    Report of the Examination of Gundersen Health Plan, Inc. La Crosse, Wisconsin As of December 31, 2017 TABLE OF CONTENTS Page I. INTRODUCTION ......................................................................................................................... 1 II. HISTORY AND PLAN OF OPERATION .................................................................................... 3 III. MANAGEMENT AND CONTROL.............................................................................................. 7 IV. AFFILIATED COMPANIES ..................................................................................................... 10 V. REINSURANCE ....................................................................................................................... 16 VI. FINANCIAL DATA ................................................................................................................... 18 VII. SUMMARY OF EXAMINATION RESULTS ........................................................................... 28 VIII. CONCLUSION ...................................................................................................................... 30 IX. SUMMARY OF COMMENTS AND RECOMMENDATIONS .................................................. 31 X. ACKNOWLEDGMENT ............................................................................................................. 32 State of Wisconsin / OFFICE OF THE COMMISSIONER OF INSURANCE 125 South Webster Street • P.O. Box 7873 Tony Evers, Governor Madison, Wisconsin 53707-7873 Mark V.
    [Show full text]
  • Tara Dall CV Feb 2019
    Tara Dall, MD, FNLA February 2019 CURRICULUM VITAE Tara Dall, MD, FNLA www.taradall.com MD21, LLC & AvanceMD http://www.MD21.com 601 Genesee Street Unit 303 www.lecturepad.org Delafield, WI 53018 www.AvanceMD.com Tel: 888-498-5296 Fax: 888-495-8194 Education November 12, 2005 Diplomate, American Board of Clinical Lipidology, Inaugural Class August 2015 Completed Institute for Functional Medicine (IFM) Applying functional medicine in clinical practice (AFMCP) program December 2001 Certified as Clinical Densitometrist from International Society for Clinical Densitometry 1998 – 2001 University of Wisconsin Madison Family Practice residency, Board Certified Family Medicine 2001 – 2008 Recertified June 2008, 2018 WI and VA state medical license 1994 – 1998 University Wisconsin Medical School (May 1998 Doctor of Medicine) 1991 – 1994 Bachelor of Science, Zoology, University Wisconsin Madison 1990 – 1991 Hope College, Holland, Michigan Employment and Board Membership January 2015 – present Physician cofounder AvanceMD Specialty Concierge, providing virtual worldwide consultation services, onsite in VA and various WI locations January 2015 - present MD21 Virtual telemedicine international concierge, founding physician January 2010- present Co-founder Lecturepad.org educational web portal July 1, 2017 –2018 Assistant Clinical Professor, Department of Medicine - Medical College of Wisconsin Tara Dall, MD, FNLA February 2019 May 2017- present Board member, Human Health Initiative, https://www.humanhealthinitiative.org/ January 2012- 2017 Chief of
    [Show full text]
  • Case Report Two Cases of the MYH9 Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells Before End-Stage Renal Failure
    Hindawi Case Reports in Nephrology Volume 2019, Article ID 5149762, 6 pages https://doi.org/10.1155/2019/5149762 Case Report Two Cases of the MYH9 Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells before End-Stage Renal Failure Shin Teshirogi,1 Jun Muratsu ,1 Hidenori Kasahara,1 Ken Terashima,1 Sho Miki,1 Tomohiro Minami,1 Yujiro Okute,1 Suguru Yoneda,1 Atsuyuki Morishima ,1 Shinji Kunishima,2 and Katsuhiko Sakaguchi 1 1Department of Nephrology and Hypertension, Sumitomo Hospital, 5-3-20 Nakanoshima, Kita-ku, Osaka 530-0005, Japan 2Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan Correspondence should be addressed to Jun Muratsu; [email protected] Received 22 June 2019; Revised 21 August 2019; Accepted 4 October 2019; Published 26 November 2019 Academic Editor: Yoshihide Fujigaki Copyright © 2019 Shin Teshirogi et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. As a MYH9 disorder, Fechtner syndrome is characterized by nephritis, giant platelets, granulocyte inclusion bodies (Döhle-like bodies), cataract, and sensorineural deafness. Observation of peripheral blood smear for the presence of thrombocytopenia, giant platelets, and granulocyte inclusion bodies (Döhle-like bodies) is highly important for the early diagnosis of MYH9 disorders. In our two cases, sequencing analysis of the MYH9 gene indicated mutations in exon 24. Both cases were diagnosed as the MYH9 disorders Fechtner syndrome before end-stage renal failure on the basis of the observation of peripheral blood smear.
    [Show full text]
  • MYH9 Mutation, the Hidden Face of Diverse Disease
    Urology & Nephrology Open Access Journal Case Report Open Access MYH9 mutation the hidden face of diverse disease spectrum - from renal perspective; renal perspective of MYH9 mutation Abstract Volume 5 Issue 4 - 2017 MYH9 (myosin heavy chain 9)-mutation is a frequent genetic disorder among African- 1 1 Americans and rare in Caucasians that can lead to dramatic deterioration of renal function Assel Rakhmetova, Pakesh Baishya, Pouneh 1 2 1 and as a consequence, end stage renal disease (ESRD). The clinical presentation of MYH9 Dokouhaki, Abdullah Alabbas, Kim Solez 1 mutations includes five syndromes: May-Hegglin anomaly, Sebastian, Fechtner, Epstein Department of laboratory medicine and pathology, University syndromes and isolated sensorineural deafness. The diagnosis is challenging to establish of Alberta hospital, Canada 2Department of pediatrics, division of nephrology, University of due to non-specific presentation that requires exclusion of a vast number of other entities. Alberta hospital, Canada Renal biopsy is not commonly performed but it may reveal non-specific findings such as mesangial expansion with hypercellularity, focal segmental glomerulosclerosis (FSGS) Correspondence: Pakesh Baishya, Department of laboratory and/or global glomerulosclerosis usually with no immune complex deposition. The medicine and pathology, University of Alberta hospital, immunostaining study for alpha-smooth muscle actin (SMA) can be valuable to perform Edmonton, Alberta, Canada, Tel 1 5875328105, in patients suspected to have MYH9 mutations in order to detect early FSGS. Additional Email studies for patients presenting with thrombocytopenia, decreasing glomerular filtration rate, proteinuria and haematuria are suggested. Here, we report a child with classic clinical picture Received: December 10, 2017 | Published: October 26, 2017 of MYH9 genetic disorder that presented with early focal segmental glomerulosclerosis with possible concurrent C1q nephropathy.
    [Show full text]
  • Genetic Disorders of the Glomerular Filtration Barrier
    CJASN ePress. Published on April 23, 2020 as doi: 10.2215/CJN.11440919 Genetic Disorders of the Glomerular Filtration Barrier Anna S. Li,1,2 Jack F. Ingham,1 and Rachel Lennon 1,3 Abstract The glomerular filtration barrier is a highly specialized capillary wall comprising fenestrated endothelial cells, podocytes, and an intervening basement membrane. In glomerular disease, this barrier loses functional integrity, allowing the passage of macromolecules and cells, and there are associated changes in both cell morphology and the extracellular matrix. Over the past three decades there has been a transformation in our understanding about glomerular disease, fueled by genetic discovery, and this is leading to exciting advances in our knowledge about 1Division of Cell- glomerular biology and pathophysiology. In current clinical practice, a genetic diagnosis already has important Matrix Biology and implications for management ranging from estimating the risk of disease recurrence post-transplant to the life- Regenerative changing advances in the treatment of atypical hemolytic uremic syndrome. Improving our understanding about Medicine, Wellcome Centre for Cell-Matrix the mechanistic basis of glomerular disease is required for more effective and personalized therapy options. In this Research, School of review we describe genotype and phenotype correlations for genetic disorders of the glomerular filtration barrier, Biological Sciences, with a particular emphasis on how these gene defects cluster by both their ontology and patterns of glomerular Faculty of Biology, pathology. Medicine and Health, CJASN ccc–ccc Manchester Academic 15: , 2020. doi: https://doi.org/10.2215/CJN.11440919 Health Science Centre, The University of Manchester, Introduction fenestrae that are 70–100 nm in diameter and covered Manchester, United .
    [Show full text]